Evidence map›Paper›PMID 37064319›Full record

ArticleHealth science reports2023

Post-COVID-19-associated multiorgan complications or "long COVID" with literature review and management strategy discussion: A meta-analysis.

Phool Iqbal, Fateen Ata, Hassan Chaudhry, Bassam Muthanna, Hafiz Waqas Younas, Syed Ata Ul Munamm, Rohit Sharma, Kahtan Fadah, Shereen Elazzazy, Anas Hamad and 2 more

Erratum issuedAbstract read
In one paragraph

Article in Health science reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Health care for patients with long COVID: a scoping review.Revista da Escola de Enfermagem da U S P · 2024
    Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Phool IqbalDepartment of Internal Medicine New York Medical College/Metropolitan Hospital Center New York New York USA.
Fateen AtaDepartment of Endocrinology Hamad Medical Corporation Doha Qatar.ORCID 0000-0001-7121-8574
Hassan ChaudhryDepartment of Respiratory Medicine University Hospital of Leicester Leicester UK.
Bassam MuthannaDepartment of Geriatrics University of Illinois at Chicago Chicago Illinois USA.
Hafiz Waqas YounasNHS Lanarkshire Leicester UK.
Syed Ata Ul MunammDepartment of Public Health Health Services Academy Islamabad Islamabad Pakistan.
Rohit SharmaDepartment of Internal Medicine Geisinger Health System Danville Pennsylvania USA.
Kahtan FadahDepartment of Internal Medicine Texas Tech University Health Sciences Center El Paso Lubbock Texas USA.
Shereen ElazzazyPharmacy Department National Centre for Cancer Care and Research, Hamad Medical Corporation Doha Qatar.
Anas HamadDepartment of Clinical Pharmacology National Centre for Cancer Care and Research, Hamad Medical Corporation Doha Qatar.
Osama Said Abu TabarCleveland Clinic Abu Dhabi, Clinical Assistant Professor of Medicine, Cleveland Clinic Lerner College of Medicine Case Western Reserve University Abu Dhabi UAE.
Nabil E OmarPharmacy Department National Centre for Cancer Care and Research, Hamad Medical Corporation Doha Qatar.ORCID 0000-0001-8291-7987

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To investigate the post-COVID-19 long-term complications or long COVID of various organ systems in patients after 3 months of the infection, specifically before the Omicron variant, with comparative literature analysis. Methods: A systemic literature search and meta-analysis were conducted using multiple electronic databases (PubMed, Scopus, Cochrane library) with predefined search terms to identify eligible articles. Eligible studies reported long-term complications of COVID-19 infection before the Omicron variant infection. Case reports, case series, observational studies with cross-sectional or prospective research design, case-control studies, and experimental studies that reported post-COVID-19 complications were included. The complications reported after 3 months after the recovery from COVID-19 infection were included in the study. Results: The total number of studies available for analysis was 34. The effect size (ES) for neurological complications was 29% with 95% confidence interval (CI): 19%-39%. ES for psychiatric complications was 24% with 95% CI: 7%-41%. ES was 9% for cardiac outcomes, with a 95% CI of 1%-18%. ES was 22%, 95% CI: 5%-39% for the gastrointestinal outcome. ES for musculoskeletal symptoms was 18% with 95% CI: 9%-28%. ES for pulmonary complications was 28% with 95% CI: 18%-37%. ES for dermatological complications was 25%, with a 95% CI of 23%-26%. ES for endocrine outcomes was 8%, with a 95% CI of 8%-9%. ES size for renal outcomes was 3% with a 95% CI of 1%-7%. At the same time, other miscellaneous uncategorized outcomes had ES of 39% with 95% CI of 21%-57%. Apart from analyzing COVID-19 systemic complications outcomes, the ES for hospitalization and intensive care unit admissions were found to be 4%, 95% CI: 0%-7%, and 11% with 95% CI: 8%-14%. Conclusion: By acquiring the data and statistically analyzing the post-COVID-19 complications during the prevalence of most virulent strains, this study has generated a different way of understanding COVID-19 and its complications for better community health.

Indexed as

COVID‐19 complicationslong COVIDMeta‐analysisPost COVID‐19SARS‐CoV‐2 sequelae

Identifiers

PMID37064319
PMCPMC10103688

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.